Revenue segments as reported by the company.

Products

Premiums

Services

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit costs

Operating expenses

Goodwill impairment

Store impairments

Opioid litigation charges

Loss on assets held for sale

Restructuring charge

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CVS Health

Aetna is an American managed health care company, which sells traditional and consumer directed health care insurance plans and related services, such as medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans. Aetna is a member of the Fortune 500.

Aetna

CVS Pharmacy is a subsidiary of the American retail and health care company CVS Health, headquartered in Woonsocket, Rhode Island. It was also known as, and originally named the Consumer Value Store and was founded in Lowell, Massachusetts, in 1963. The chain was owned by its original holding company Melville Corporation since its inception until its current parent company CVS Health was spun off into its own company in 1996. CVS Pharmacy is currently the largest pharmacy chain in the United States by number of locations (over 9,600 as of 2016) and total prescription revenue. As the retail pharmacy division of CVS Health, it ranks as the 7th largest U.S. corporation according to Fortune 500 in 2016. CVS Pharmacy's leading competitor Walgreens Boots Alliance ranked 37th.

CVS Pharmacy

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CVS Health exceeds Q4 expectations, eyes growth with Oak Street

CVS Health's strong financial performance in 2022, driven by revenue growth and exceeding EPS expectations, positions the company well for future growth.
The acquisition of Oak Street Health presents opportunities to expand into primary care and improve long-term earnings growth, despite challenges in maintaining retail performance.

CVS Health excels in Q1, eyes growth through acquisitions and innovation

CVS Health's strong financial performance, strategic acquisitions, and customer-centric initiatives position the company for sustained growth and competitive advantage.
While facing challenges in the evolving healthcare landscape, CVS Health's focus on innovation, affordability, and operational efficiency provides a solid foundation for future success.
By capitalizing on opportunities in growth, synergies, and healthcare services, CVS Health can navigate industry headwinds and drive long-term value creation for stakeholders.

CVS Health reports robust Q2 earnings, eyes growth opportunities

CVS Health's Q2 2023 performance reflects strong financial results and strategic acquisitions driving growth.
Despite challenges like higher costs and restructuring charges, the company remains confident in its ability to deliver outstanding performance.
Opportunities lie in expanding Medicaid contracts, biosimilar market establishment, and clinic openings for at-risk populations.
Overall, CVS Health's focus on cost optimization, digital sales growth, and patient engagement positions it well for future success.

CVS Health reports robust Q3 earnings and strategic growth plans

CVS Health's Q3 performance reflects strong financial results and strategic initiatives across its segments, positioning the company for sustainable growth.
While facing challenges like declining vaccine demand and contract losses, CVS Health is focused on leveraging opportunities in biosimilars and cost-saving solutions.
The company's commitment to operational excellence, innovation, and workforce investment underscores its strategic vision for becoming a leading health solutions provider.
With a clear focus on growth drivers and mitigating challenges, CVS Health is poised to capitalize on market opportunities and deliver value to shareholders.

CVS Health reports robust Q4 earnings, eyes Medicare margin recovery

CVS Health's Q4 2023 earnings call highlighted strong financial performance, a cautious stance on Medicare Advantage utilization, and a focus on transforming healthcare delivery. The company is committed to margin recovery, growth, and enhancing customer experience while addressing challenges in Medicare Advantage trends and cost pressures.

CVS Health faces Medicare Advantage challenges, focuses on margin improvement

CVS Health's Q1 2024 earnings call highlighted strong financial performance, challenges in the Medicare Advantage business, and a focus on improving margins. The company showcased strengths in the biosimilar market and Pharmacy & Consumer Wellness segment while addressing issues impacting Health Care Benefits and Services segments.

CVS Health's Q2 2024 performance reflects strong financial results, cost savings, and innovative initiatives in pharmacy services.
The company faces challenges in the Health Care Benefits segment but is actively addressing them through leadership changes and operational improvements.
Opportunities for growth include driving margin improvements, expanding digital reach, and educating stakeholders on the value delivery of PBMs.
Expectation of margin recovery in Medicare Advantage and double-digit EPS growth in 2025 highlight CVS Health's strategic focus on operational efficiencies and cost savings.

CVS Health reports robust Q3 earnings, focuses on growth strategies

CVS Health's Q3 2024 performance was marked by strong financial results, leadership changes, and segment-specific challenges and successes. The company is focused on leveraging opportunities in strategic initiatives and addressing areas for improvement to drive future growth.

Revenue

Cost of revenue

Gross profit

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Although the revenue and EPS for CVS Health (CVS) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

CVS Health (CVS) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

CVS Health Corp (NYSE:CVS) bobbed and weaved to put the best gloss on its third-quarter earnings update early on – only to see the stock flop 4.2% premarket. Okay, the good news was that the bottom-line numbers for the last three months exceeded the Street's expectations.

CVS shares drop 4.2% on guidance downgrade

AbbVie

Analog Devices

Applied Materials

Advanced Micro Devices

AMETEK

ANSYS

Broadcom

Bath and Body Works

ON Semiconductor

Tired of the S&P 500's three-month losing streak? Help might be on the way in November.

November Is The S&P 500's Best Month — 10 Stocks Rally Every Time

CVS Health reported third quarter net income of $2.2 billion thanks in part to contributions from its new healthcare services acquisitions.

CVS Health Profits Eclipse $2.2 Billion As Company Integrates New Provider Businesses

CVS revises lower its guidance range for diluted GAAP earnings per share for the third straight quarter.

CVS Earnings Top Estimates but Stock Drops as Outlook Slashed Again

CVS Health Corp.'s stock CVS was up 0.8% premarket Wednesday, after the drug store chain posted stronger-than-expected third-quarter earnings, shrugging off lower profit guidance for the full year. The company had net income of $2.265 billion, or $1.75 a share, for the quarter, after a loss of $3.399 billion, or $2.59 a share, in the year-earlier period.

CVS Health's stock up after earnings beat, but company lowers full-year EPS guidance

CVS Health Corp beat Wall Street estimates for quarterly profit on Wednesday as strength in its drugstores and pharmacy benefit management business offset higher-than-expected medical costs at its insurance unit.

CVS profit beats estimates on strong performance of pharmacy operations

WOONSOCKET, R.I. , Nov. 1, 2023 /PRNewswire/ -- CVS Health Corporation (NYSE: CVS) today announced operating results for the three months ended September 30, 2023.

CVS Health reports third quarter results

Pharmaceutical concern CVS Health Corp (NYSE:CVS) will enter the earnings confessional before the open tomorrow.

Pharma Giant Prepares for Earnings Call

Rite Aid

Rite Aid Corp

Walgreens

Workers at pharmacy companies CVS (NYSE: CVS ), Walgreens (NASDAQ: WBA ) and RiteAid (OTCMKTS: RADCQ ) have staged a strike that has them walking out on the businesses for three days to highlight working conditions The strikes at CVS, Walgreens and RiteAid are focused on unsafe working conditions. Employees of these companies are focusing on how understaffed locations are, requiring a daunting amount of work for the company's workers.

Strike Alert 2023: Workers at CVS, Walgreens, Rite Aid Walk Out

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Wall Street Analysts Look Bullish on CVS Health (CVS): Should You Buy?

Aetna CVS Health Individual and Family Plans combine the quality health insurance coverage of Aetna®, with affordable care options at CVS Pharmacy® and MinuteClinic® locations to help members achieve their best health. WOONSOCKET, R.I.

Aetna CVS Health to enter the Affordable Care Act (ACA) individual insurance exchange marketplace in Indiana for January 1, 2024

Aetna CVS Health to enter the Affordable Care Act (ACA) individual insurance exchange marketplace in Kansas for January 1, 2024

Aetna CVS Health to enter the Affordable Care Act (ACA) individual insurance exchange marketplace in Maryland for January 1, 2024

Aetna CVS Health to enter the Affordable Care Act (ACA) individual insurance exchange marketplace in Ohio for January 1, 2024

Aetna CVS Health to enter the Affordable Care Act (ACA) individual insurance exchange marketplace in Utah for January 1, 2024

Thousands of employees at CVS Health Corp and Walgreens Boots Alliance's U.S. pharmacies are planning a three-day walkout starting Monday, in an attempt to get the companies to improve working conditions and recruit more people, among other issues.

Pharmacy staff from CVS, Walgreens stores in US plan 3-day walkout

Alphabet

Amid the prevailing financial uncertainty, let's explore two stocks that are worth considering for investment.

Short squeeze alert: 2 stocks that could rocket next month

Workers are concerned that Walgreens and CVS are placing unreasonable demands on them, without providing enough resources to safely execute tasks.

Pharmacy staff from Walgreens, CVS say they're at a breaking point — here's what their days look like

Bristol-Myers

Shares of CVS Health and Bristol Myers Squibb are down more than 20% year to date. Both businesses, however, have some promising growth opportunities ahead.

2 Absurdly Cheap Healthcare Stocks to Buy and Hold for Decades

CVS Health (CVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CVS Health (CVS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

CVS Health Corp (NYSE:CVS) will report its third quarter 2023 financial results on November 1, with analysts calling for earnings per share (EPS) of $2.13, reflecting a year-over-year increase of just 2% according to Zacks Investment Research.   The healthcare company has a recent history of exceeding EPS expectations and Zacks believes CVS can do the same in 3Q.

CVS Health could see another earnings surprise in 3Q: analysts

CVS Health can derive strong synergy benefits from their pharmacies, health insurance, and PBM businesses. CVS Health's debt load is manageable and offers the opportunity to acquire a number of Rite Aid drugstores. However, there is a big shark lurking: Amazon Pharmacy.

CVS Health: Rite Aid's Chapter 11 Provides Opportunity

CVS Health's shares have not changed much over the past five years. The company is a leader in a sector that currently appears to be undervalued. Valuation suggests the company's intrinsic value lies much higher.

CVS Health: A Bargain Long-Term Opportunity

CVS Health experienced a rise in revenue in Q2 2023 and is scheduled to announce Q3 2023 earnings on November 1, 2023. The company is undergoing a comprehensive restructuring to improve efficiency and cut costs.

News for CVS Health Stock (CVS)